Medication adherence is a complex issue, and Lonny Reisman, MD, CEO of HealthReveal, emphasized the importance of better understanding what methods or strategies will help motivate patients to do what is in their best interest.
Medication adherence is a complex issue, and Lonny Reisman, MD, CEO of HealthReveal, emphasized the importance of better understanding what methods or strategies will help motivate patients to do what is in their best interest.
Transcript (slightly modified)
How can big data help with improving medication adherence?
So the issue of medication adherence is complex. There could be cost issues. There could be side-effect issues. There can be issues around a relative lack of symptoms associated with certain diseases. Basically, even poor glycemic control at certain levels won’t create symptoms. So the issue is as we identify patients who are adherent or we test hypothesis regarding what would drive incentives to take medicines, we will be able to learn what would work across poor populations.
One of the issues I’ve been involved with, or at least when I was at Aetna, was value-based insurance design where we would lower or eliminate co-pays for certain essential therapeutics for certain patients. And although we saw increases in adherence when drugs were given say for free, we actually rarely saw improvements over 50% adherence. So to the extent that people who have had serious diseases won’t even take their medicines for free, it underscores the importance of understanding better how we can motivate people to do what ultimately is in their best interest.
Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer
March 28th 2024This analysis included 119 patients with advanced lung cancer, who were evaluated on 3 facets of physical activity over 14 days of using the amuelink wearable device from Sony: metabolic equivalent tasks, distance walked, and steps taken.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Machine Learning Model Predicts Hepatocellular Carcinoma Risk in Patients With MASLD
March 22nd 2024Machine learning models have potential for early identification of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) who are at risk of hepatocellular carcinoma.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More